Vir Biotechnology, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Vir Biotechnology, Inc. reported Cash And Cash Equivalents At Carrying Value of $232.19 million for the year ending 2025.

  • Vir Biotechnology, Inc. showed an increase of +4.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Vir Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Vir Biotechnology, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 23.6%.
  • Historical annual values: Fiscal year 2025: $232.19 million | Fiscal year 2024: $222.95 million | Fiscal year 2023: $241.58 million | Fiscal year 2022: $848.63 million | Fiscal year 2021: $347.82 million | Fiscal year 2020: $436.58 million | Fiscal year 2019: $109.34 million | Fiscal year 2018: $47.60 million | Fiscal year 2017: $187.92 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: